Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Patent
1995-06-13
1997-04-29
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
424464, 424465, 424468, 424473, 514770, 5147722, 5147723, 514774, 514778, 514779, 514781, A61K 922, A61K 926
Patent
active
056246773
ABSTRACT:
A composition providing a relatively slow release of water-soluble drugs, such as apomorphine, for delivery via the sublingual or buccal routes.
REFERENCES:
patent: 2818855 (1958-01-01), Miller
patent: 3428728 (1969-02-01), Lowey
patent: 4127118 (1978-11-01), Latorre
patent: 4801587 (1989-01-01), Voss et al.
patent: 5256652 (1993-10-01), El-Rashidy
patent: 5419917 (1995-05-01), Chen et al.
Deffond, D, et al. J. Neurol. Neurosurg. and Psych. 56:101-103 (1993).
Droller, M.J. et al. Impotence. Consensus Development Conference Statement, National Institutes of Health J.A.M.A. 270:83-90 (1993).
Heaton, J.P.W. et al. Urology 45: 200-206 (1995).
Kirby, R.S. British Medical J. 308: 957-961 (1994).
Muhtadi, F.J. and M.S. Hifnawy, Analytical Profile of Apomorphine Hydrochloride, in Analytical Profiles of Drug Substances, Klaus Florely Ed., vol. 20, Academic Press, Inc. New York (1991).
Murray, F.T. et al. Amer. J. Medical Sci. 309:99-109 (1995).
O'Keefe, M. et al. Medical Clinics of North America 79:415-434 (1995).
Seagraves, R.T. et al. J. Urology 145:1174-1175 (1991).
Vickers, M.A., et al. J. Urology 149:1258-1261 (1993).
El-Rashidy Ragab
Hassan Emad E.
Ronsen Bruce
Page Thurman K.
Pentech Pharmaceuticals, Inc.
Spear James M.
LandOfFree
Controlled release of drugs delivered by sublingual or buccal ad does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled release of drugs delivered by sublingual or buccal ad, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release of drugs delivered by sublingual or buccal ad will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-704024